Efficacy, safety, and pharmacokinetics of natalizumab in Japanese multiple sclerosis patients: A double-blind, randomized controlled trial and open-label pharmacokinetic study
- Takahiko Saida
- , Jun ichi Kira
- , Shuji Kishida
- , Takashi Yamamura
- , Yukiko Sudo
- , Kazutaka Ogiwara
- , J. T. Tibung
- , Nisha Lucas
- , Meena Subramanyam
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読
24
リンクは新しいタブで開きます
被引用数
(Scopus)